Home › Clinical Tools › Lipid panel

🫀 Lipid Panel Interpretation

UseInterpret a lipid panel against the patient's risk level, not a single fixed cut-off.

Loading calculator…

SourceESC/EAS 2019 dyslipidaemia guideline; Chinese lipid guideline

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Scene next step
📋ASCVD / China-PAROpen scene pack →
Related scores
Matching pathway
🧭htn_emergencyOpen pathway →
Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

LDL target follows ASCVD risk stratification, which differs slightly by guideline.

When to use

Interpret a lipid panel against the patient's risk level, not a single fixed cut-off.

How it works

LDL targets: very high < 1.4, high < 1.8, moderate < 2.6, low < 3.4 mmol/L. Non-HDL target ≈ LDL target + 0.8 mmol/L.

Key points

  • LDL target follows ASCVD risk stratification, which differs slightly by guideline.
  • Severe hypertriglyceridaemia (≥ 5.6 mmol/L) prioritises pancreatitis prevention.
  • Lp(a) is an independent hereditary risk — measure at least once.
  • ApoB reflects atherogenic particle number for residual-risk assessment.

References

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

ViewLDL target (by risk)

→LipidsLDL target (by ASCVD risk)

  • Very high risk：< 1.4 mmol/L (55 mg/dL) and ≥ 50% reduction from baseline
  • High risk：< 1.8 mmol/L (70 mg/dL) and ≥ 50% reduction
  • Moderate risk：< 2.6 mmol/L (100 mg/dL)
ViewReference cut-offs

→LipidsLipid reference cut-offs (adult, fasting)

  • LDL-C：Optimal < 2.6 mmol/L (100 mg/dL); ≥ 3.4 (130) high; ≥ 4.9 (190) very high
  • HDL-C：Low: men < 1.0, women < 1.3 mmol/L (< 40 / < 50 mg/dL)
  • TG：Desirable < 1.7 mmol/L (150); 1.7–2.3 borderline; ≥ 2.3 high
Verification & sources · governance
FAQ

Frequently asked questions

What are the limits and cautions when using Lipid Panel Interpretation?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Lipid Panel Interpretation upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Lipid Panel Interpretation calculated in practice? Can you show a worked example?
Inputs: View LDL target (by risk) → Result: Lipids LDL target (by ASCVD risk)（Very high risk: < 1.4 mmol/L (55 mg/dL) and ≥ 50% reduction from baseline, High risk: < 1.8 mmol/L (70 mg/dL) and ≥ 50% reduction, Moderate risk: < 2.6 mmol/L (100 mg/dL)） Inputs: View Reference cut-offs → Result: Lipids Lipid reference cut-offs (adult, fasting)（LDL-C: Optimal < 2.6 mmol/L (100 mg/dL); ≥ 3.4 (130) high; ≥ 4.9 (190) very high, HDL-C: Low: men < 1.0, women < 1.3 mmol/L (< 40 / < 50 mg/dL), TG: Desirable < 1.7 mmol/L (150); 1.7–2.3 borderline; ≥ 2.3 high）
Related tools

Other tools